---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-000199"
form_type: "8-K"
ticker: "FHTX"
cik: "0001822462"
company_name: "Foghorn Therapeutics Inc."
filed_at: "2024-01-03T23:59:59+00:00"
generated_at: "2026-06-07T04:47:17.968500+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Foghorn Therapeutics CFO Allan Reine resigns effective Jan 16, 2024

## Summary
- CFO Allan Reine resigns to pursue other opportunity; effective Jan 16, 2024.
- Departure not due to any disagreement with company's operations, policies, or financial controls.
- Company has commenced formal search for a successor; CEO thanked Reine for his leadership.
- Dr. Reine's last full-time day will be January 16, 2024.

## SEC filing metadata
- accession: 0001628280-24-000199
- form_type: 8-K
- ticker: FHTX
- cik: 0001822462
- company_name: Foghorn Therapeutics Inc.
- filed_at: 2024-01-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822462/000162828024000199/0001628280-24-000199-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822462/000162828024000199/fhtx-20231229.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-000199
- JSON: https://secwatch.observer/filing/0001628280-24-000199.json
- Plain text: https://secwatch.observer/filing/0001628280-24-000199.txt

## Key facts
- Executive change
  Allan Reine resigned as Chief Financial Officer at Foghorn Therapeutics Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Allan Reine, M.D. notified Foghorn Therapeutics Inc. (the "Company") of his decision to resign as Chief Financial Officer, effective January 16, 2024, to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822462/000162828024000199/0001628280-24-000199-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.